TP53 and cervical cancer: Moreover, this lack of reliability of p53 as a senescence marker in cervical cancer tissue can also be observed with its downstream effector p21Cip1, which, in this work, showed variable expression levels among different precancerous samples, confirming its previously postulated low utility as a senescence marker in certain models [45].